{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T08:06:55Z","timestamp":1788336415415,"version":"build-2803163510"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2016,9,13]],"date-time":"2016-09-13T00:00:00Z","timestamp":1473724800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1007\/s13277-016-5325-2","type":"journal-article","created":{"date-parts":[[2016,9,12]],"date-time":"2016-09-12T23:38:45Z","timestamp":1473723525000},"page":"14667-14675","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Aberrant microRNA expression in tumor mycosis fungoides"],"prefix":"10.1007","volume":"37","author":[{"given":"E.","family":"Papadavid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Braoudaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bourdakou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Lykoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Nikolaou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Tounta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ekonomidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Athanasiadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Spyrou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Antoniou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Kitsiou-Tzeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Rigopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Kolialexi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,13]]},"reference":[{"issue":"6","key":"5325_CR1","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1182\/blood-2007-03-055749","volume":"110","author":"E Olsen","year":"2007","unstructured":"Olsen E, Vonderheid E, Pimpinelli N, Willemze R, Kim Y, Knobler R, et al. Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of cancer (EORTC. Blood. 2007;110(6):1713\u201322. doi: 10.1182\/blood-2007-03-055749 .","journal-title":"Blood"},{"issue":"4","key":"5325_CR2","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1396-0296.2003.01640.x","volume":"16","author":"YH Kim","year":"2003","unstructured":"Kim YH. Management with topical nitrogen mustard in mycosis fungoides. Dermatol Ther. 2003;16(4):288\u201398.","journal-title":"Dermatol Ther"},{"issue":"32","key":"5325_CR3","doi-asserted-by":"publisher","first-page":"3766","DOI":"10.1200\/JCO.2015.61.7142","volume":"33","author":"JJ Scarisbrick","year":"2015","unstructured":"Scarisbrick JJ, Prince HM, Vermeer MH, Quaglino P, Horwitz S, Porcu P, et al. Cutaneous lymphoma international consortium study of outcome in advanced stages of mycosis fungoides and Sezary syndrome: effect of specific prognostic markers on survival and development of a prognostic model. J Clin Oncol. 2015;33(32):3766\u201373. doi: 10.1200\/JCO.2015.61.7142 .","journal-title":"J Clin Oncol"},{"key":"5325_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-016-4903-7","author":"M Braoudaki","year":"2016","unstructured":"Braoudaki M, Lambrou GI, Giannikou K, Papadodima SA, Lykoudi A, Stefanaki K, et al. miR-15a and miR-24-1 as putative prognostic microRNA signatures for pediatric pilocytic astrocytomas and ependymomas. Tumour Biol. 2016. doi: 10.1007\/s13277-016-4903-7 .","journal-title":"Tumour Biol"},{"key":"5325_CR5","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s13045-014-0096-y","volume":"7","author":"M Braoudaki","year":"2014","unstructured":"Braoudaki M, Lambrou GI, Giannikou K, Milionis V, Stefanaki K, Birks DK, et al. Microrna expression signatures predict patient progression and disease outcome in pediatric embryonal central nervous system neoplasms. J Hematol Oncol. 2014;7:96. doi: 10.1186\/s13045-014-0096-y .","journal-title":"J Hematol Oncol"},{"key":"5325_CR6","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13045-014-0101-5","volume":"8","author":"M Braoudaki","year":"2015","unstructured":"Braoudaki M, Lambrou GI. MicroRNAs in pediatric central nervous system embryonal neoplasms: the known unknown. J Hematol Oncol. 2015;8:6. doi: 10.1186\/s13045-014-0101-5 .","journal-title":"J Hematol Oncol"},{"issue":"3","key":"5325_CR7","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.molonc.2011.02.003","volume":"5","author":"MS Kester van","year":"2011","unstructured":"van Kester MS, Ballabio E, Benner MF, Chen XH, Saunders NJ, van der Fits L, et al. miRNA expression profiling of mycosis fungoides. Mol Oncol. 2011;5(3):273\u201380. doi: 10.1016\/j.molonc.2011.02.003 .","journal-title":"Mol Oncol"},{"issue":"4","key":"5325_CR8","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1038\/jid.2014.487","volume":"135","author":"J Sandoval","year":"2015","unstructured":"Sandoval J, Diaz-Lagares A, Salgado R, Servitje O, Climent F, Ortiz-Romero PL, et al. MicroRNA expression profiling and DNA methylation signature for deregulated microRNA in cutaneous T-cell lymphoma. J Invest Dermatol. 2015;135(4):1128\u201337. doi: 10.1038\/jid.2014.487 .","journal-title":"J Invest Dermatol."},{"issue":"Web Server issu","key":"5325_CR9","doi-asserted-by":"publisher","first-page":"W498","DOI":"10.1093\/nar\/gks494","volume":"40","author":"IS Vlachos","year":"2012","unstructured":"Vlachos IS, Kostoulas N, Vergoulis T, Georgakilas G, Reczko M, Maragkakis M, et al. DIANA miRPath v.2.0: investigating the combinatorial effect of microRNAs in pathways. Nucleic Acids Res. 2012;40(Web Server issue):W498\u2013504. doi: 10.1093\/nar\/gks494 .","journal-title":"Nucleic Acids Res"},{"issue":"Web Server issu","key":"5325_CR10","doi-asserted-by":"publisher","first-page":"W169","DOI":"10.1093\/nar\/gkt393","volume":"41","author":"MD Paraskevopoulou","year":"2013","unstructured":"Paraskevopoulou MD, Georgakilas G, Kostoulas N, Vlachos IS, Vergoulis T, Reczko M, et al. DIANA-microT web server v5.0: service integration into miRNA functional analysis workflows. Nucleic Acids Res. 2013;41(Web Server issue):W169\u201373. doi: 10.1093\/nar\/gkt393 .","journal-title":"Nucleic Acids Res"},{"issue":"Web Server issu","key":"5325_CR11","doi-asserted-by":"publisher","first-page":"W77","DOI":"10.1093\/nar\/gkt439","volume":"41","author":"J Wang","year":"2013","unstructured":"Wang J, Duncan D, Shi Z, Zhang B. WEB-based GEne SeT AnaLysis toolkit (WebGestalt): update 2013. Nucleic Acids Res. 2013;41(Web Server issue):W77\u201383. doi: 10.1093\/nar\/gkt439 .","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"5325_CR12","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s12253-015-9897-8","volume":"21","author":"D Marosvari","year":"2015","unstructured":"Marosvari D, Teglasi V, Csala I, Marschalko M, Bodor C, Timar B, et al. Altered microRNA expression in folliculotropic and transformed mycosis fungoides. Pathol Oncol Res. 2015;21(3):821\u20135. doi: 10.1007\/s12253-015-9897-8 .","journal-title":"Pathol Oncol Res"},{"issue":"12","key":"5325_CR13","doi-asserted-by":"publisher","first-page":"3144","DOI":"10.1038\/jid.2015.328","volume":"135","author":"F Gallardo","year":"2015","unstructured":"Gallardo F, Sandoval J, Diaz-Lagares A, Garcia R, D\u2019Altri T, Gonzalez J, et al. Notch1 pathway activation results from the epigenetic abrogation of notch-related MicroRNAs in mycosis fungoides. J Invest Dermatol. 2015;135(12):3144\u201352. doi: 10.1038\/jid.2015.328 .","journal-title":"J Invest Dermatol."},{"issue":"2","key":"5325_CR14","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/j.1365-2133.2011.10669.x","volume":"166","author":"J Maj","year":"2012","unstructured":"Maj J, Jankowska-Konsur A, Sadakierska-Chudy A, Noga L, Reich A. Altered microRNA expression in mycosis fungoides. Br J Dermatol. 2012;166(2):331\u20136. doi: 10.1111\/j.1365-2133.2011.10669.x .","journal-title":"Br J Dermatol."},{"issue":"4","key":"5325_CR15","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/jid.2013.461","volume":"134","author":"LY McGirt","year":"2014","unstructured":"McGirt LY, Adams CM, Baerenwald DA, Zwerner JP, Zic JA, Eischen CM. miR-223 regulates cell growth and targets proto-oncogenes in mycosis fungoides\/cutaneous T-cell lymphoma. J Invest Dermatol. 2014;134(4):1101\u20137. doi: 10.1038\/jid.2013.461 .","journal-title":"J Invest Dermatol."},{"issue":"7","key":"5325_CR16","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1182\/blood-2009-12-256719","volume":"116","author":"E Ballabio","year":"2010","unstructured":"Ballabio E, Mitchell T, van Kester MS, Taylor S, Dunlop HM, Chi J, et al. MicroRNA expression in Sezary syndrome: identification, function, and diagnostic potential. Blood. 2010;116(7):1105\u201313. doi: 10.1182\/blood-2009-12-256719 .","journal-title":"Blood"},{"issue":"12","key":"5325_CR17","first-page":"7207","volume":"34","author":"U Ralfkiaer","year":"2014","unstructured":"Ralfkiaer U, Lindahl LM, Litman T, Gjerdrum LM, Ahler CB, Gniadecki R, et al. MicroRNA expression in early mycosis fungoides is distinctly different from atopic dermatitis and advanced cutaneous T-cell lymphoma. Anticancer Res. 2014;34(12):7207\u201317.","journal-title":"Anticancer Res"},{"issue":"3","key":"5325_CR18","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.cellsig.2014.12.003","volume":"27","author":"X Wang","year":"2015","unstructured":"Wang X, Li J, Dong K, Lin F, Long M, Ouyang Y, et al. Tumor suppressor miR-34a targets PD-L1 and functions as a potential immunotherapeutic target in acute myeloid leukemia. Cell Signal. 2015;27(3):443\u201352. doi: 10.1016\/j.cellsig.2014.12.003 .","journal-title":"Cell Signal"},{"issue":"2","key":"5325_CR19","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/leu.2013.298","volume":"28","author":"J Boysen","year":"2014","unstructured":"Boysen J, Sinha S, Price-Troska T, Warner SL, Bearss DJ, Viswanatha D, et al. The tumor suppressor axis p53\/miR-34a regulates Axl expression in B-cell chronic lymphocytic leukemia: implications for therapy in p53-defective CLL patients. Leukemia. 2014;28(2):451\u20135. doi: 10.1038\/leu.2013.298 .","journal-title":"Leukemia"},{"issue":"6","key":"5325_CR20","doi-asserted-by":"publisher","first-page":"963","DOI":"10.3892\/mmr_00000199","volume":"2","author":"Y Yao","year":"2009","unstructured":"Yao Y, Suo AL, Li ZF, Liu LY, Tian T, Ni L, et al. MicroRNA profiling of human gastric cancer. Mol Med Rep. 2009;2(6):963\u201370. doi: 10.3892\/mmr_00000199 .","journal-title":"Mol Med Rep"},{"issue":"3","key":"5325_CR21","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1002\/ijc.23948","volume":"124","author":"E Ferretti","year":"2009","unstructured":"Ferretti E, De Smaele E, Po A, Di Marcotullio L, Tosi E, Espinola MS, et al. MicroRNA profiling in human medulloblastoma. Int J Cancer. 2009;124(3):568\u201377. doi: 10.1002\/ijc.23948 .","journal-title":"Int J Cancer"},{"issue":"10","key":"5325_CR22","doi-asserted-by":"publisher","first-page":"e25114","DOI":"10.1371\/journal.pone.0025114","volume":"6","author":"FF Costa","year":"2011","unstructured":"Costa FF, Bischof JM, Vanin EF, Lulla RR, Wang M, Sredni ST, et al. Identification of microRNAs as potential prognostic markers in ependymoma. PLoS One. 2011;6(10):e25114. doi: 10.1371\/journal.pone.0025114 .","journal-title":"PLoS One"},{"key":"5325_CR23","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.jprot.2013.09.009","volume":"94","author":"R Ruiz Esparza-Garrido","year":"2013","unstructured":"Ruiz Esparza-Garrido R, Velazquez-Flores MA, Diegoperez-Ramirez J, Lopez-Aguilar E, Siordia-Reyes G, Hernandez-Ortiz M, et al. A proteomic approach of pediatric astrocytomas: MiRNAs and network insight. J Proteome. 2013;94:162\u201375. doi: 10.1016\/j.jprot.2013.09.009 .","journal-title":"J Proteome"},{"issue":"22","key":"5325_CR24","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1038\/onc.2010.634","volume":"30","author":"E Sotillo","year":"2011","unstructured":"Sotillo E, Laver T, Mellert H, Schelter JM, Cleary MA, McMahon S, et al. Myc overexpression brings out unexpected antiapoptotic effects of miR-34a. Oncogene. 2011;30(22):2587\u201394. doi: 10.1038\/onc.2010.634 .","journal-title":"Oncogene"},{"issue":"4","key":"5325_CR25","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1089\/nat.2012.0343","volume":"22","author":"M Rizzo","year":"2012","unstructured":"Rizzo M, Mariani L, Cavallini S, Simili M, Rainaldi G. The over-expression of miR-34a fails to block DoHH2 lymphoma cell proliferation by reducing p53 via c-MYC down-regulation. Nucleic Acid Ther. 2012;22(4):283\u20138. doi: 10.1089\/nat.2012.0343 .","journal-title":"Nucleic Acid Ther"},{"issue":"4","key":"5325_CR26","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1038\/jid.2009.306","volume":"130","author":"R Salgado","year":"2010","unstructured":"Salgado R, Servitje O, Gallardo F, Vermeer MH, Ortiz-Romero PL, Karpova MB, et al. Oligonucleotide array-CGH identifies genomic subgroups and prognostic markers for tumor stage mycosis fungoides. J Invest Dermatol. 2010;130(4):1126\u201335. doi: 10.1038\/jid.2009.306 .","journal-title":"J Invest Dermatol."},{"issue":"15","key":"5325_CR27","doi-asserted-by":"publisher","first-page":"12837","DOI":"10.18632\/oncotarget.3805","volume":"6","author":"N Amodio","year":"2015","unstructured":"Amodio N, Rossi M, Raimondi L, Pitari MR, Botta C, Tagliaferri P, et al. miR-29\u00a0s: a family of epi-miRNAs with therapeutic implications in hematologic malignancies. Oncotarget. 2015;6(15):12837\u201361. doi: 10.18632\/oncotarget.3805 .","journal-title":"Oncotarget"},{"key":"5325_CR28","doi-asserted-by":"publisher","first-page":"539","DOI":"10.2147\/OTT.S75899","volume":"8","author":"B Yan","year":"2015","unstructured":"Yan B, Guo Q, FJ F, Wang Z, Yin Z, Wei YB, et al. The role of miR-29b in cancer: regulation, function, and signaling. Onco Targets Ther. 2015;8:539\u201348. doi: 10.2147\/OTT.S75899 .","journal-title":"Onco Targets Ther"},{"key":"5325_CR29","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/2162-3619-3-17","volume":"3","author":"L Xu","year":"2014","unstructured":"Xu L, Xu Y, Jing Z, Wang X, Zha X, Zeng C, et al. Altered expression pattern of miR-29a, miR-29b and the target genes in myeloid leukemia. Exp Hematol Oncol. 2014;3:17. doi: 10.1186\/2162-3619-3-17 .","journal-title":"Exp Hematol Oncol"},{"issue":"2","key":"5325_CR30","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.1038\/bcj.2012.1","volume":"2","author":"L Di Lisio","year":"2012","unstructured":"Di Lisio L, Sanchez-Beato M, Gomez-Lopez G, Rodriguez ME, Montes-Moreno S, Mollejo M, et al. MicroRNA signatures in B-cell lymphomas. Blood. Cancer J. 2012;2(2):e57. doi: 10.1038\/bcj.2012.1 .","journal-title":"Cancer J"},{"issue":"12","key":"5325_CR31","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1038\/sj.leu.2404853","volume":"21","author":"E Ruiz-Ballesteros","year":"2007","unstructured":"Ruiz-Ballesteros E, Mollejo M, Mateo M, Algara P, Martinez P, Piris MA. MicroRNA losses in the frequently deleted region of 7q in SMZL. Leukemia. 2007;21(12):2547\u20139. doi: 10.1038\/sj.leu.2404853 .","journal-title":"Leukemia"},{"issue":"1","key":"5325_CR32","doi-asserted-by":"publisher","first-page":"95","DOI":"10.7534\/j.issn.1009-2137.2013.01.020","volume":"21","author":"HB Huang","year":"2013","unstructured":"Huang HB, Zhan R, SQ W, ZZ X, Fan LP. Expression of MCL-1 and microRNA-29a in extranodal NK\/T-cell lymphoma tissue. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013;21(1):95\u20138. doi: 10.7534\/j.issn.1009-2137.2013.01.020 .","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"issue":"1","key":"5325_CR33","first-page":"33","volume":"9","author":"N Saki","year":"2015","unstructured":"Saki N, Abroun S, Soleimani M, Hajizamani S, Shahjahani M, Kast RE, et al. Involvement of MicroRNA in T-cell differentiation and malignancy. Int J Hematol Oncol Stem Cell Res. 2015;9(1):33\u201349.","journal-title":"Int J Hematol Oncol Stem Cell Res"},{"issue":"2","key":"5325_CR34","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3233\/CBM-150563","volume":"16","author":"Y Zhu","year":"2016","unstructured":"Zhu Y, Xu A, Li J, Fu J, Wang G, Yang Y, et al. Fecal miR-29a and miR-224 as the noninvasive biomarkers for colorectal cancer. Cancer Biomark. 2016;16(2):259\u201364. doi: 10.3233\/CBM-150563 .","journal-title":"Cancer Biomark"},{"issue":"1","key":"5325_CR35","doi-asserted-by":"publisher","first-page":"F19","DOI":"10.1677\/ERC-09-0184","volume":"17","author":"B Boyerinas","year":"2010","unstructured":"Boyerinas B, Park SM, Hau A, Murmann AE, Peter ME. The role of let-7 in cell differentiation and cancer. Endocr Relat Cancer. 2010;17(1):F19\u201336. doi: 10.1677\/ERC-09-0184 .","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"5325_CR36","doi-asserted-by":"publisher","first-page":"6353","DOI":"10.3390\/ijms16036353","volume":"16","author":"K Dang","year":"2015","unstructured":"Dang K, Myers KA. The role of hypoxia-induced miR-210 in cancer progression. Int J Mol Sci. 2015;16(3):6353\u201372. doi: 10.3390\/ijms16036353 .","journal-title":"Int J Mol Sci"},{"key":"5325_CR37","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1756-9966-33-50","volume":"33","author":"Q Qin","year":"2014","unstructured":"Qin Q, Furong W, Baosheng L. Multiple functions of hypoxia-regulated miR-210 in cancer. J Exp Clin Cancer Res. 2014;33:50. doi: 10.1186\/1756-9966-33-50 .","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"5325_CR38","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.clim.2013.10.009","volume":"150","author":"M Zhao","year":"2014","unstructured":"Zhao M, Wang LT, Liang GP, Zhang P, Deng XJ, Tang Q, et al. Up-regulation of microRNA-210 induces immune dysfunction via targeting FOXP3 in CD4(+) T cells of psoriasis vulgaris. Clin Immunol. 2014;150(1):22\u201330. doi: 10.1016\/j.clim.2013.10.009 .","journal-title":"Clin Immunol"},{"issue":"4","key":"5325_CR39","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1111\/j.1365-2133.2007.08427.x","volume":"158","author":"MR Kamstrup","year":"2008","unstructured":"Kamstrup MR, Ralfkiaer E, Skovgaard GL, Gniadecki R. Potential involvement of Notch1 signalling in the pathogenesis of primary cutaneous CD30-positive lymphoproliferative disorders. Br J Dermatol. 2008;158(4):747\u201353. doi: 10.1111\/j.1365-2133.2007.08427.x .","journal-title":"Br J Dermatol."},{"issue":"14","key":"5325_CR40","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1182\/blood-2009-12-260216","volume":"116","author":"MR Kamstrup","year":"2010","unstructured":"Kamstrup MR, Gjerdrum LM, Biskup E, Lauenborg BT, Ralfkiaer E, Woetmann A, et al. Notch1 as a potential therapeutic target in cutaneous T-cell lymphoma. Blood. 2010;116(14):2504\u201312. doi: 10.1182\/blood-2009-12-260216 .","journal-title":"Blood"},{"issue":"4","key":"5325_CR41","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nrm2868","volume":"11","author":"M Inui","year":"2010","unstructured":"Inui M, Martello G, Piccolo S. MicroRNA control of signal transduction. Nat Rev Mol Cell Biol. 2010;11(4):252\u201363. doi: 10.1038\/nrm2868 .","journal-title":"Nat Rev Mol Cell Biol"},{"key":"5325_CR42","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.6476","author":"J Masliah-Planchon","year":"2015","unstructured":"Masliah-Planchon J, Garinet S, Pasmant E. RAS-MAPK pathway epigenetic activation in cancer: miRNAs in action. Oncotarget. 2015. doi: 10.18632\/oncotarget.6476 .","journal-title":"Oncotarget"},{"issue":"3","key":"5325_CR43","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1093\/jmcb\/mju018","volume":"6","author":"JM Liao","year":"2014","unstructured":"Liao JM, Cao B, Zhou X, Lu H. New insights into p53 functions through its target microRNAs. J Mol Cell Biol. 2014;6(3):206\u201313. doi: 10.1093\/jmcb\/mju018 .","journal-title":"J Mol Cell Biol"},{"issue":"4","key":"5325_CR44","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1007\/s13277-013-1481-9","volume":"35","author":"VP Sivadas","year":"2014","unstructured":"Sivadas VP, Kannan S. The microRNA networks of TGFbeta signaling in cancer. Tumour Biol. 2014;35(4):2857\u201369. doi: 10.1007\/s13277-013-1481-9 .","journal-title":"Tumour Biol"},{"issue":"17","key":"5325_CR45","doi-asserted-by":"publisher","first-page":"3886","DOI":"10.1200\/JCO.2005.11.353","volume":"23","author":"R Doorn van","year":"2005","unstructured":"van Doorn R, Zoutman WH, Dijkman R, de Menezes RX, Commandeur S, Mulder AA, et al. Epigenetic profiling of cutaneous T-cell lymphoma: promoter hypermethylation of multiple tumor suppressor genes including BCL7a, PTPRG, and p73. J Clin Oncol. 2005;23(17):3886\u201396. doi: 10.1200\/JCO.2005.11.353 .","journal-title":"J Clin Oncol"},{"issue":"3","key":"5325_CR46","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/jid.2009.314","volume":"130","author":"A Pham-Ledard","year":"2010","unstructured":"Pham-Ledard A, Prochazkova-Carlotti M, Laharanne E, Vergier B, Jouary T, Beylot-Barry M, et al. IRF4 gene rearrangements define a subgroup of CD30-positive cutaneous T-cell lymphoma: a study of 54 cases. J Invest Dermatol. 2010;130(3):816\u201325. doi: 10.1038\/jid.2009.314 .","journal-title":"J Invest Dermatol"},{"issue":"18","key":"5325_CR47","doi-asserted-by":"publisher","first-page":"8101","DOI":"10.1158\/0008-5472.CAN-04-0366","volume":"65","author":"L Karenko","year":"2005","unstructured":"Karenko L, Hahtola S, Paivinen S, Karhu R, Syrja S, Kahkonen M, et al. Primary cutaneous T-cell lymphomas show a deletion or translocation affecting NAV3, the human UNC-53 homologue. Cancer Res. 2005;65(18):8101\u201310. doi: 10.1158\/0008-5472.CAN-04-0366 .","journal-title":"Cancer Res"},{"issue":"3","key":"5325_CR48","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1111\/j.1365-2133.2010.10108.x","volume":"164","author":"N Booken","year":"2011","unstructured":"Booken N, Heck M, Nicolay JP, Klemke CD, Goerdt S, Utikal J. Oral aprepitant in the therapy of refractory pruritus in erythrodermic cutaneous T-cell lymphoma. Br J Dermatol. 2011;164(3):665\u20137. doi: 10.1111\/j.1365-2133.2010.10108.x .","journal-title":"Br J Dermatol"},{"issue":"3","key":"5325_CR49","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/ddg.12900","volume":"14","author":"JP Nicolay","year":"2016","unstructured":"Nicolay JP, Felcht M, Schledzewski K, Goerdt S, Geraud C. Sezary syndrome: old enigmas, new targets. J Dtsch Dermatol Ges. 2016;14(3):256\u201364. doi: 10.1111\/ddg.12900 .","journal-title":"J Dtsch Dermatol Ges"},{"issue":"1","key":"5325_CR50","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1159\/000321959","volume":"156","author":"G Nagy","year":"2011","unstructured":"Nagy G, Gaspar K, Irinyi B, Gal M, Tumpek J, Gyimesi E, et al. Association between serum IL-16 levels and the degree of sensitization in patients with atopic dermatitis. Int Arch Allergy Immunol. 2011;156(1):69\u201374. doi: 10.1159\/000321959 .","journal-title":"Int Arch Allergy Immunol"},{"issue":"1","key":"5325_CR51","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s10875-010-9464-8","volume":"31","author":"J Richmond","year":"2011","unstructured":"Richmond J, Tuzova M, Parks A, Adams N, Martin E, Tawa M, et al. Interleukin-16 as a marker of Sezary syndrome onset and stage. J Clin Immunol. 2011;31(1):39\u201350. doi: 10.1007\/s10875-010-9464-8 .","journal-title":"J Clin Immunol"},{"issue":"1","key":"5325_CR52","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/039463201102400103","volume":"24","author":"KG Wu","year":"2011","unstructured":"Wu KG, Li TH, Chen CJ, Cheng HI, Wang TY. Correlations of serum interleukin-16, total IgE, eosinophil cationic protein and total eosinophil counts with disease activity in children with atopic dermatitis. Int J Immunopathol Pharmacol. 2011;24(1):15\u201323.","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"3","key":"5325_CR53","doi-asserted-by":"crossref","first-page":"222","DOI":"10.2174\/187221312802652820","volume":"6","author":"J Lee","year":"2012","unstructured":"Lee J, Noh G, Lee S, Youn Y, Rhim J. Atopic dermatitis and cytokines: recent patents in immunoregulatory and therapeutic implications of cytokines in atopic dermatitis--part I: cytokines in atopic dermatitis. Recent Patents Inflamm Allergy Drug Discov. 2012;6(3):222\u201347.","journal-title":"Recent Patents Inflamm Allergy Drug Discov"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-016-5325-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-016-5325-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-016-5325-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T18:38:19Z","timestamp":1498329499000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-016-5325-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,13]]},"references-count":53,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["5325"],"URL":"https:\/\/doi.org\/10.1007\/s13277-016-5325-2","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,13]]}}}